Paradigm for Parity (P4P), a nonprofit, supporting companies around the world in achieving their commitment to gender parity in corporate leadership, today announced the expansion of its Center for Action and the appointment of Debbie Polishook to its Board of Directors.
“Our recently launched Center for Action brings together best in class service providers and mission-aligned nonprofits to support our coalition member companies in closing the gender leadership gap,” stated Paradigm for Parity CEO, Nadine Bullock-Pottinga.
New program partners in the Paradigm for Parity Center for Action include:
Catalyst, a global nonprofit dedicated to driving gender equity through workplace inclusion, creates workplaces that work for women. Paradigm for Parity’s members can now access Catalyst’s MARC (Men Advocating Real Change) Leaders immersive workshop, a fee-for-service program delivered by Catalyst experts. Catalyst’s MARC Leaders is an interactive cross-company immersive learning experience for directors through senior executives that inspires participants to stand up for gender equity. The program increases effective gender partnership, builds skills to communicate more courageously and inclusively across gender and other forms of difference, and provides tools to enable and support a culture of inclusion through disruptive dialogue.
Simmons University for Inclusive Leadership, is a global authority on inclusive leadership and gender equity, focused on fostering equity in leadership and advancing women leaders in organizations globally. The Institute delivers research-based programming designed to develop greater understanding of inclusive leadership and identify specific actions that anyone can take to lead more inclusively.
Girls With Impact (GWI), is the nation’s only live, online business and leadership program for young women, equipping them with skills, tools, and mentoring to thrive and advance in the workplace. GWI will support the coalition member companies by offering their mini-“MBA” program, which teaches essential business acumen to early career women employees.
They join current Center for Action partners AceUp,  Linkage, a SHRM company, LiveGirl, and TONE Networks.
In step with its programmatic expansion, Paradigm for Parity also announced the addition of Debbie Polishook to its Board of Directors.
Debbie is the Former Group Chief Executive of Accenture Operations who led a top-line double digit growth $6B+ portfolio of business process services (BPO). She is a results-driven strategic thinker, mentor, and problem solver with a long track record of envisioning and executing transformative change, deploying leading edge technologies such as blockchain, RPA (Robotic Process Automation) and machine learning/artificial intelligence for a multitude of Fortune 500 companies.
P4P Board President, Jewelle Bickford, commented, “Debbie’s global experience in leading operations combined with her deep knowledge of technologies including artificial intelligence brings a new dimension of expertise to our Board at a pivotal time in our growth as an organization.”
Ms. Polishook also serves as a corporate Board Director for Wawa, Inc., Micro Focus, Trinity Consultants and Globality, Inc. and one not-for profit Board, C200 (an organization focused on the advancement of women corporate executives and entrepreneurs). She previously served on the board of Avanade, an Accenture/Microsoft JV offering innovative technology solutions and managed services based on Microsoft technologies.
“I am honored to join the Paradigm for Parity board. There is so much at stake for women, the business community and society to close the gender leadership gap quickly,” said Ms. Polishook
The post Paradigm for Parity Expands to Close Gender Leadership Gap appeared first on HIPTHER Alerts.

 
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of the Medical Technologies to Watch in 2024 report. This first installment of a two-part series offers a comprehensive predictive analysis of high-growth medical technology markets poised to generate over $1 billion in value or achieve double-digit growth within the next five years.
The report underscores critical areas of significant investment. Clarivate medtech analysts pinpoint five technologies driving substantial clinical and commercial value in devices and diagnostics this year. These innovations hold immense promise for patients, potentially complementing or even supplanting traditional medications and biochemical solutions.
April Chan-Tsui, Director, Medtech Insights, Life Sciences & Healthcare, Clarivate said: “Despite the challenges of the past five years, the medtech industry has shown remarkable resilience, driving forward with groundbreaking technological advancements. Backed by in-depth industry expertise and robust data, this report highlights recent breakthroughs poised to significantly improve patient outcomes. These innovations represent the forefront of medtech’s journey towards extraordinary impact.”
The Five 2024 Medical Technologies to Watch are:

Pulsed field ablation devicesPulsed field ablation (PFA) has emerged as a promising treatment for atrial fibrillation (AF), garnering significant attention from the cardiac ablation community. PFA employs electric pulses, not heat, that help in the electroporation of the myocardium without collateral damage to normal heart tissue. Compared to established treatment options, PFA has remarkably low recurrence rates, shorter treatment durations and higher success rates.
Diabetes care devicesDiabetes care technology is poised for significant growth in the near future, driven by ongoing advancements. Beyond these developments, significant activity is also underway in developing alternative treatment options for diabetes management, including new drug therapies and medical procedures that could potentially impact the growth of the diabetes care technology market in the coming years.
Neurostimulation devicesThe multibillion-dollar implantable neurostimulation device market will grow as new and incumbent competitors expand treatable indications and launch new devices with design and lifespan improvements. The hypoglossal nerve stimulation device (HGNS) market has, in particular, witnessed rapid growth, and it is expected to surpass most other neurostimulation device markets in size in upcoming years.
Surgical roboticsSurgical robotic systems are revolutionizing the field of medicine, offering better visualization, increased precision, and better ergonomics for surgeons. These systems go beyond simple robotic systems, providing a platform for minimally invasive surgeries with benefits for both surgeons and patients. Despite being considered innovative technology, robotics has become increasingly common; in the orthopedics space, for example, all major companies now offer a robotic system and have had to do so to remain competitive against their leading peers.
Renal denervationThe hypertension management market will regain its momentum with the dawn of the long-awaited age of renal denervation (RDN) technology. 2023 was eventful with the U.S. approvals of devices from Recor Medical and Medtronic poised to impact the hypertension management market in 2024 and beyond.

Exciting technologies are emerging in the medtech sector, but the industry faces challenges including shifting service sites in the critical U.S. market, global supply chain disruptions, the rise of GLP-1 receptor agonists, the emergence of AI/ML, and the fast-changing policy landscape. These challenges will be addressed in part two of the Medtech Trends to Watch report.
Access the full Medical Technologies to Watch in 2024 report from Clarivate, here.
For more Medical Technologies to Watch updates and analyses throughout the year, visit the Medical Technologies to Watch web page and follow Clarivate for Life Sciences & Healthcare on LinkedIn and X. Join the conversation, using #MedicalTechnologiesToWatch.
To learn more about how Clarivate can help medtech companies evolve their commercialization strategies and answer new types of business questions by obtaining actionable medtech insights across the entire R&D lifecycle, visit here.
Methodology
To identify this year’s Medical Technologies to Watch, Clarivate drew from the expertise of over 40 analysts, covering over 80 medical device markets across more than 50 countries globally, and integrated medtech intelligence datasets that span the R&D and commercialization life cycle, along with other industry sources, including company press releases, financial filings and peer-reviewed publications. Clarivate proprietary data and solutions used include Medtech 360, commercial targeting (Procedure Finder/Healthbase), tracking tools (Marketrack/PriceTrack), and Cortellis Competitive Intelligence and Cortellis Deals Intelligence and other real world data analyses, including claims data and government data analytics.
Clarivate analysts utilized our new Data Explorer application to highlight markets that have a total forecast market value of more than $1 billion or more by 2028 or have rapid growth rates with high market values. Clarivate experts and analysts evaluated each medical technology in its individual context based on factors such as expected device approval or launch dates, reimbursement potential, competitive landscape, regulatory status, trial results, market dynamics and other key factors.
The post Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024 appeared first on HIPTHER Alerts.

 
Prime, an international hyperscale and wholesale data center provider, today announced plans to develop a 26,000 square-meter data center in Madrid, Spain. The company has secured 7.6 acres in Alcobendas with plan to develop a facility that will be able deliver 40 megawatts of critical power. Alcobendas is the largest in-country data center ecosystem with 41 percent of the live, colocation power consumption. Prime Madrid will be developed according to customer demand and will address hyperscale cloud and artificial intelligence power density requirements.
“With forty-four megawatts of take-up in 2023, power challenges limiting FLAPD markets, and information governance mandating in-country data center presence, it is clear that Madrid is poised for strong growth over the foreseeable future,” commented Nicholas Laag, Founder and CEO of Prime Data Centers. “Alcobendas is an ideal location for Prime’s first data center in Madrid with an established ecosystem that offers easy access to fiber and experienced, skilled labor.”
Prime selected Madrid for its latest expansion on account of the market’s strong, hyperscale demand base which represented an estimated 74% of 2023 take-up across self-build and colocation data centers. Additionally, Madrid’s central location serves a large population base while acting as the primary network relay point for coastal regions and Portugal. Prime Madrid will be located at Calle de la Pedriza 1, Alcobendas in immediate proximity to local Internet Exchange Points for customer network optimization.
“Having spent the last twenty-five years in Madrid, it is encouraging to see the hard work and preparation put in by so many local stakeholders result in readiness to capitalize on the recent surge in demand,” said Michael Wall, Senior Vice President of Development and Construction for Prime in Europe. “Prime believes this strong foundation will sustain data center growth in Madrid further validating its place alongside the most influential digital infrastructure markets in Europe. We are excited to contribute to the success story.”
Prime’s three-plus gigawatt roadmap now includes twenty-two owned and optioned locations in the United States and Europe as well as numerous others in active due diligence. Recent announcements include nearly 500 megawatts across Denmark, Phoenix and Chicago. Prime also projects the opening of its partially pre-leased Los Angeles data center in October 2024.
Visit primedatacenters.com/madrid-data-centers for more information.
The post Prime Data Centers Announces Plans for 40MW Madrid Data Center appeared first on HIPTHER Alerts.